Features of chronic hepatitis C in a patient with metabolic syndrome (clinical case)

Objective: To study the features of chronic hepatitis C in a 17-year-old patient with metabolic syndrome. Results: The article presents a clinical example of the course of chronic hepatitis C (HCV) in a 17-year-old patient with metabolic syndrome. He fell ill at the age of 13 and was seen by an infectious disease specialist. Antiviral therapy was not prescribed. A complete examination was conducted with an assessment of laboratory data. Biochemical activity, severity of liver fibrotic changes and signs of metabolic syndrome (MS) were compared. To assess the component composition of the body, a bioimpedance analysis was performed. Additionally, in order to identify associative links between gene polymorphism and MS components, the genetic profile of the patient and his parents was studied. Conclusion: A patient with genetic predictors of metabolic syndrome should be previously prescribed antiviral therapy for chronic hepatitis C.

Authors

Institutions

Publication Details

Journal
CHILDREN INFECTIONS
Published
2024-09-26
DOI
https://doi.org/10.22627/2072-8107-2024-23-3-62-64
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Features of chronic hepatitis C in a patient with metabolic syndrome (clinical case)

V. L. Rozina, И. Г. Ситников, M. S. Bokhonov, A. A. Koklyushkina
CHILDREN INFECTIONS
Liver Disease Diagnosis and Treatment
article

Features of chronic hepatitis C in a patient with metabolic syndrome (clinical case)

V. L. Rozina, И. Г. Ситников, M. S. Bokhonov, A. A. Koklyushkina
article en

Abstract

Objective: To study the features of chronic hepatitis C in a 17-year-old patient with metabolic syndrome. Results: The article presents a clinical example of the course of chronic hepatitis C (HCV) in a 17-year-old patient with metabolic syndrome. He fell ill at the age of 13 and was seen by an infectious disease specialist. Antiviral therapy was not prescribed. A complete examination was conducted with an assessment of laboratory data. Biochemical activity, severity of liver fibrotic changes and signs of metabolic syndrome (MS) were compared. To assess the component composition of the body, a bioimpedance analysis was performed. Additionally, in order to identify associative links between gene polymorphism and MS components, the genetic profile of the patient and his parents was studied. Conclusion: A patient with genetic predictors of metabolic syndrome should be previously prescribed antiviral therapy for chronic hepatitis C.

CHILDREN INFECTIONSVol. 23(3)
Yaroslavl State Medical Academy (RU), Ministry of Health of the Russian Federation (RU)
Good health and well-being
Openalex Percentile: Top 75%
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.